(Q24245281)

https://api.crossref.org/works/10.1002%2F14651858.CD005002.PUB2

Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005002.PUB2

Estrogen-receptor-directed neoadjuvant therapy for breast cancer: results of a randomised trial using formestane and methotrexate, mitozantrone and mitomycin C (MMM) chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005002.PUB2

Good clinical response of breast cancers to neoadjuvant chemoendocrine therapy is associated with improved overall survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005002.PUB2

Preoperative FLAC/granulocyte-colony-stimulating factor chemotherapy for stage II breast cancer: a prospective randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005002.PUB2

Randomized trial comparing neo-adjuvant versus adjuvant chemotherapy in operable locally advanced breast cancer (T4b N0-2 M0).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005002.PUB2

Gene expression profiles predict complete pathologic response to neoadjuvant paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide chemotherapy in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005002.PUB2

Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005002.PUB2

Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005002.PUB2

Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005002.PUB2

Neoadjuvant vinorelbine/epirubicin (VE) versus standard adriamycin/cyclophosphamide (AC) in operable breast cancer: analysis of response and tolerability in a randomised phase III trial (TOPIC 2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005002.PUB2

Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005002.PUB2

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005002.PUB2

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005002.PUB2

Local recurrence after breast-conserving therapy for invasive breast cancer: high incidence in young patients and association with poor survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005002.PUB2

Phase III randomized trial of doxorubicin and docetaxel versus doxorubicin and cyclophosphamide as primary medical therapy in women with breast cancer: an anglo-celtic cooperative oncology group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005002.PUB2

A randomized clinical trial evaluating sequential methotrexate and fluorouracil in the treatment of patients with node-negative breast cancer who have estrogen-receptor-negative tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005002.PUB2

Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005002.PUB2

Local recurrence in the breast after conservative surgery--a study of prognosis and prognostic factors in 391 women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005002.PUB2

Changes in gene expression associated with response to neoadjuvant chemotherapy in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005002.PUB2

Quantifying heterogeneity in a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005002.PUB2

Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005002.PUB2

International expert panel on the use of primary (preoperative) systemic treatment of operable breast cancer: review and recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005002.PUB2

The impact of breast-conserving treatment and mastectomy on the quality of life of early-stage breast cancer patients: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005002.PUB2

Predictors of patients' choices for breast-conserving therapy or mastectomy: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005002.PUB2

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005002.PUB2

The role of magnetic resonance imaging in diagnosis and management of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005002.PUB2

Chemotherapy before and after mastectomy in stage III breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005002.PUB2

Advanced primary breast cancer: assessment at mammography of response to induction chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005002.PUB2

Neoadjuvant treatment of postmenopausal breast cancer with anastrozole, tamoxifen, or both in combination: the Immediate Preoperative Anastrozole, Tamoxifen, or Combined with Tamoxifen (IMPACT) multicenter double-blind randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005002.PUB2

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005002.PUB2

Impact of locoregional treatment on the early-stage breast cancer patients: a retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005002.PUB2

Prognosis after treatment for loco-regional recurrence after mastectomy or breast conserving therapy in two randomised trials (EORTC 10801 and DBCG-82TM). EORTC Breast Cancer Cooperative Group and the Danish Breast Cancer Cooperative Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005002.PUB2

Does locoregional radiation therapy improve survival in breast cancer? A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005002.PUB2

Primary systemic therapy in operable breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005002.PUB2

Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005002.PUB2

Beta blockade during and after myocardial infarction: an overview of the randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005002.PUB2

Statistical Methods for Examining Heterogeneity and Combining Results from Several Studies in Meta-Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005002.PUB2

Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: the National Cancer Institute Randomized Trial

21 January 2018

1 reference

12 December 2020

Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18

1 reference

12 December 2020

Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis. Danish Breast Cancer Cooperative Group.

1 reference

12 December 2020

Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial

1 reference

12 December 2020

Preoperative chemotherapy followed by mastectomy for locally advanced breast cancer

1 reference

12 December 2020

Neo-adjuvant chemotherapy for operable breast cancer induces apoptosis

1 reference

12 December 2020

A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer

1 reference

12 December 2020

Assessment of response to therapy in advanced breast cancer: a project of the Programme on Clinical Oncology of the International Union Against Cancer, Geneva, Switzerland

1 reference

12 December 2020

Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer: the results of 20 years of follow-up

1 reference

12 December 2020

Survival advantage of adjuvant chemotherapy in high-risk node-negative breast cancer: ten-year analysis--an intergroup study

1 reference

12 December 2020

Effect of preoperative chemotherapy on the outcome of women with operable breast cancer

1 reference

12 December 2020

Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: preliminary results of a randomised trial: S6

1 reference

12 December 2020

Preoperative chemotherapy: a model for studying the biology and therapy of primary breast cancer

1 reference

12 December 2020

Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer

1 reference

12 December 2020

Primary (neoadjuvant) chemotherapy and radiotherapy compared with primary radiotherapy alone in stage IIb-IIIa breast cancer

1 reference

12 December 2020

Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer:National Surgical Adjuvant Breast and Bowel Project Protocol B-27

1 reference

12 December 2020

Neoadjuvant chemotherapy in the conservative management of breast cancer: a study of 252 patients

1 reference

12 December 2020

Risk factors for local recurrence after breast-conserving surgery

1 reference

12 December 2020

Prospective randomized study of surgical morbidity following primary systemic therapy for breast cancer

1 reference

12 December 2020

Effects of preoperative chemotherapy on the morphology of resectable breast carcinoma

1 reference

12 December 2020

Long-term prognosis of patients with local recurrence after conservative surgery and radiotherapy for early breast cancer

1 reference

12 December 2020

1 reference

12 December 2020

Short and long-term effects on survival in breast cancer patients treated by primary chemotherapy: an updated analysis of a randomized trial

1 reference

12 December 2020

Neoadjuvant chemotherapy in operable breast cancer

1 reference

12 December 2020

Breast tumour response to primary chemotherapy predicts local and distant control as well as survival

1 reference

12 December 2020

Multimodal treatment of locoregionally advanced breast cancer

1 reference

12 December 2020

Primary breast cancer: mammographic changes after neoadjuvant chemotherapy, with pathologic correlation

1 reference

12 December 2020

Evaluation of neoadjuvant chemotherapeutic response of locally advanced breast cancer by magnetic resonance imaging

1 reference

12 December 2020

Late local recurrences in a randomised trial comparing conservative treatment with total mastectomy in early breast cancer patients

1 reference

12 December 2020

Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: a unicentre randomized trial with a 124-month median follow-up. Institut Bergonié Bordeaux Groupe Sein (IBBGS)

1 reference

12 December 2020

Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer

1 reference

12 December 2020

Conservation surgery after primary chemotherapy in large carcinomas of the breast

1 reference

12 December 2020